/

Editas Medicine

Developing CRISPR-based gene editing therapies for serious diseases.

BiotechnologyPharmaceuticals editasmedicine.com ↗

Company facts

Founded: 2013
Employees: 186
Headquarters: United States
Type: Public
Listed: NASDAQ: EDIT
Subsidiaries: i2 Pharmaceuticals